Regional Medical Scientific Director - Northwest

Geron Corporation•United States,

1d•$230,000 - $245,000•Remote

About The Position

The Regional Medical Scientific Director serves as a trusted partner for internal stakeholders and the healthcare community engaging in scientific exchange and relevant dialogue to enhance medical education, generate data and insights, and support patient access to medicine. The position will have a territory of WA, OR, ID, MT, WY, UT, CO, and AK. This position is remote and will report to the Senior Director, National Field Medical Team.

Requirements

Detailed knowledge of clinical medicine, disease management, patient treatment trends, national/regional healthcare and access environment, clinical trial design, and competitive landscape in malignant hematology/oncology
Proven ability to work independently as well as in cross-functional networks in a high growth, fast-paced environment
Current knowledge of scientific and treatment landscape trends in malignant hematology
Excellent communication, presentation, and time management skills
Strong interpersonal skills and ability to establish, maintain, and grow professional relationships
Possess a thorough understanding of US legal, regulatory, and compliance regulations and guidelines relevant to industry interactions with external and internal partners
Demonstrated knowledge of CRM tools, Microsoft Office products, and virtual engagement platforms
MD, PharmD, DNP, PhD; advanced or doctoral degree in scientific discipline with substantial and relevant pharmaceutical or biotechnology experience
At least 5 years in US Field Medical, Medical Affairs, or related industry roles
Professional licensure, certifications, and credentials must be active, in good standing, and maintained
Valid Driver’s license and satisfactory MVR record
Must meet all credentialing requirements for access to academic institutions, medical facilities, and organizations that are in the assigned geography; these credentialing requirements may include, but are not limited to, background checks, drug screens, and proof of immunization and/or vaccinations

Nice To Haves

Clinical experience in hematologic malignancies, preferred

Responsibilities

Identifies, develops, and maintains peer-to-peer scientific relationships with Healthcare Professionals (HCPs) in lower risk MDS, MF, and AML; connects with HCPs in academic and community centers as per the Medical Affairs plan and goals
Serves as a scientific resource to external HCPs and internal stakeholders by staying up-to-date on latest training materials, scientific and clinical literature, evolving competitive landscape, and any other relevant information necessary to remain a subject matter expert
Collaborates across multiple functions and within a region to maximize territory opportunities
Provides fair and balanced scientific information and education to HCPs on published imetelstat data, disease management, treatment landscapes, mechanisms of action, and molecular pathways, in accordance with Company directives
Partners with research and development functional groups to support Company-sponsored clinical trial enrollment and imetelstat lifecycle management
Act as a primary liaison to investigators interested in developing and performing investigator-sponsored research
Collaborates with physicians on Medical Affairs initiatives, including publications, medical education opportunities, training, and speaker development
Communicates clinical insights to internal cross-functional partners to inform medical strategy
Trains internal stakeholders and field partners on key scientific and medical topics, as appropriate
Maintains effective and appropriate communication among internal stakeholders while ensuring full compliance with relevant requirements
Generates compliant territory plans to provide needs-based, value-added support of the medical and scientific community in line with Company goals
Maintains timely and accurate reporting and documentation of all activities with HCPs
Travel domestically and internationally approximately up to 75% of the time